Showing 1 - 13 results of 13 for search 'Hasan Şenol COŞKUN', query time: 0.05s
Refine Results
-
1
Toxoplasma gondii Infection in a Patient With Non-Hodgkin’s Lymphoma by Hasan Şenol COŞKUN, Mustafa SAMUR, Dilek DİNÇOL
Published 1999-03-01
Article -
2
-
3
-
4
-
5
Investigation of Constipation Frequency and Development Risk in Cancer Patients by Nazlı Öztürk, Burcu Çelik Kocabıyık, Fatma Arıkan, Hasan Şenol Coşkun
Published 2020-07-01
Article -
6
Follicular Thyroid Carcinoma with Metastases to the Breast: An Unusual Case by Çağatay Arslan, Hasan Şenol Coşkun, Sema Sezgin Göksu, Özden Çandır
Published 2014-01-01
Article -
7
-
8
-
9
-
10
Coexistence of Gastric Adenocarcinoma and Choriocarcinoma: Complete Response to Trastuzumab and Chemotherapy by Seyda Gunduz, Gulsum Ozlem Elpek, Mukremin Uysal, Sema Sezgin Goksu, Murat Tatlı, Deniz Arslan, Hasan Senol Coşkun, Hakan Bozcuk, Burhan Savas, Mustafa Ozdogan
Published 2012-07-01
Article -
11
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PA... by Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap
Published 2020-03-01
Article -
12
Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treate... by Nuri Karadurmus, Mehmet Ali Nahit Sendur, Burcak Karaca, Omer Fatih Olmez, Ilhan Hacibekiroglu, Hasan Senol Coskun, Serkan Degirmencioglu, Yasemin Kemal, Saadettin Kilickap, Ahmet Taner Sumbul, Burc Aydin, Hande Turna, Muhammet Ali Kaplan, Nalan Babacan, Umut Demirci, Alper Ata, Dilek Erdem, Ahmet Ozet, Huseyin Abali
Published 2018-12-01
Article -
13
Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients by Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün
Published 2021-09-01
Article